Feasibility of low dose interleukin-2 therapy following T cell-depleted non-myeloablative allogeneic hematopoietic stem cell transplantation from HLA matched or mismatched family member donors

High relapse rates and infections remain primary causes of failure in non-myeloablative transplantation. Interleukin-2 (IL-2) may stimulate the immune system and improve outcomes. The primary objective of this pilot study was to evaluate the feasibility of administering IL-2 following a T cell-deple...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rizzieri, David A., Crout, Christopher, Storms, Robert, Golob, Jared, Long, Gwynn D., Gasparetto, Cristina, Sullivan, Keith M., Horwitz, Mitchell, Chute, John, Lagoo, Anand S., Morris, Ashley, Beaven, Anne, Yang, Yiping, Peterson, Bercedis, Li, Zhiguo, Chao, Nelson J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3619422/
https://ncbi.nlm.nih.gov/pubmed/21166499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/07357907.2010.535055
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky